Filter by Category: In Vitro Activity

Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection.

Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection. by Lewis RE, Klepser ME, Ernst EJ, Lund BC, Biedenbach DJ and Jones RN published in Antimicrob. Agents Chemother. 1999; 43 (8): 2005-2009

In vitro evaluation of cefepime and other broad-spectrum β-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study Group.

In vitro evaluation of cefepime and other broad-spectrum β-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study Group. by Lewis MT, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 1999; 35 (4): 285-290

In vitro evaluation of cefepime and other broad-spectrum β-lactams in 22 medical centers in Japan: A phase II trial comparing two annual organism samples. The Japan Antimicrobial Resistance Study Group.

In vitro evaluation of cefepime and other broad-spectrum β-lactams in 22 medical centers in Japan: A phase II trial comparing two annual organism samples. The Japan Antimicrobial Resistance Study Group. by Lewis MT, Yamaguchi K, Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 1999; 35 (4): 307-315

In vitro evaluation of broad-spectrum β-lactams tested in medical centers in Korea: Role of fourth-generation cephalosporins. The Korean Antimicrobial Resistance Study Group.

In vitro evaluation of broad-spectrum β-lactams tested in medical centers in Korea: Role of fourth-generation cephalosporins. The Korean Antimicrobial Resistance Study Group. by Lewis MT, Biedenbach DJ, and Jones RN published in Diagn. Microbiol. Infect. Dis. 1999; 35 (4): 317-323

Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone.

Development of in vitro susceptibility testing methods for gemifloxacin (formerly LB20304a or SB-265805), an investigational fluoronaphthyridone. by Jones RN, Erwin ME, Biedenbach DJ, Johnson DM and Pfaller MA published in Diagn. Microbiol. Infect. Dis. 1999; 35 (3): 227-234

In vitro activity of gatifloxacin tested against anaerobic bacteria by reference agar dilution and Etest methods.

In vitro activity of gatifloxacin tested against anaerobic bacteria by reference agar dilution and Etest methods. by Jones RN, Barrett MS and Pfaller MA published in Clin. Microbiol. Infect. 1999; 5 (9): 577-579

Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.

Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results. by Biedenbach DJ, Jones RN, Lewis MT, Croco MA, and Barrett MS published in Diagn. Microbiol. Infect. Dis. 1999; 33 (4): 275-282

Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and Etest methods.

Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and Etest methods. by Biedenbach DJ, Croco MA, Barrett TJ and Jones RN published in Eur. J. Clin. Microbiol. Infect. Dis. 1999; 18 (6): 428-431

In vitro evaluation of cefepime and other broad-spectrum β-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study Group.

In vitro evaluation of cefepime and other broad-spectrum β-lactams for isolates in Malaysia and Singapore medical centers. The Malaysia/Singapore Antimicrobial Resistance Study Group. by Biedenbach DJ, Lewis MT and Jones RN published in Diagn. Microbiol. Infect. Dis. 1999; 35 (4): 277-283

In vitro evaluation of cefepime and other broad-spectrum β-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study Group.

In vitro evaluation of cefepime and other broad-spectrum β-lactams in Taiwan medical centers. The Taiwan Antimicrobial Resistance Study Group. by Biedenbach DJ, Johnson DM and Jones RN published in Diagn. Microbiol. Infect. Dis. 1999; 35 (4): 299-305